Ocular absorption of benzydamine by the rabbit
โ Scribed by B. Catanese; P. Valeri; A. Lagana; L. Curini
- Publisher
- John Wiley and Sons
- Year
- 1989
- Tongue
- English
- Weight
- 175 KB
- Volume
- 10
- Category
- Article
- ISSN
- 0142-2782
No coin nor oath required. For personal study only.
โฆ Synopsis
An aqueous solution of 0.15 per cent benzydamine hydrochloride, a non-steroidal antiinflammatory drug, was applied to the rabbit eye. Following topical application to the cornea, the drug was soon detected in the aqueous fluid of the treated eye, whereas the plasma levels were negligible. The possibility that benzydamine can inhibit inflammatory processes in the eye without the risk of side-effects is discussed.
๐ SIMILAR VOLUMES
An oxazolidine prodrug of phenylephrine and the base form of phenylephrine were synthesized, suspended in sesame oil, and tested for mydriatic activity against phenylephrine HCI. The HCI salt was formulated as a viscous aqueous solution and as a sesame oil suspension. A dosing volume of 10 pl was in
The pharmacologically active compound (33% reduction in rabbit intraocular pressure recovery rate assay) 1-ethyl-6-fluoro-1,2,3,4-tetrahydroquinoline (MC4), which showed ocular hypotensive action and had optimum physicochemical properties, was characterized for its ocular absorption and distribution
The ionic environment of the eye is involved in major biochemical processes which are essential for preserving the integrity of cornea and lens. The purpose of the present study was to determine the intra-ocular penetration and the pharmacokinetic parameters of calcium, chloride and sulphate ions in